Cabio Biotech (Wuhan) Co., Ltd. (688089.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Basic Materials
Industry
Chemicals - Specialty
Employees
595
First IPO Date
August 12, 2022
| Name | Title | Pay | Year Born |
| Huarong Yi | Deputy GM & Secretary of the Board of Directors | 0 | 1976 |
| Zhi Bo Li | Deputy General Manager | 0 | 1973 |
| Dewei Yi | Chairman & GM | 0 | 1965 |
| Huabiao Wang | Financial Director & Director | 0 | 1965 |
| Hao Xiong | Accounting Supervisor | 0 | N/A |
| Xiangyu Li | Deputy General Manager | 0 | 1978 |
| Anfeng Geng | Deputy General Manager | 0 | 1976 |
Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production and sale of polyunsaturated fatty acids and nutrition products. Its products include arachidonic acids (ARA), docosahexaenoic acids (DHA), natural beta-carotene products, infant formula food, functional healthcare food and dietary supplements. The company was founded on September 22, 2004 and is headquartered in Wuhan, China.